Niraparib

ZEJULA

NADAC/unit N/A

No Shortage Tier 1: 53.8% PA Req: 298.2%

AKEEGA with prednisone is indicated for the treatment of adult patients with deleterious or suspected deleterious BRCA2 -mutated ( BRCA2 m) metastatic castration-sensitive prostate cancer (mCSPC).

Covered Lives

Generic Manufacturers

GLAXOSMITHKLINE LLC

Explore in the Ecosystem

rxsaver.aiCompare prices for Niraparib drfinder.aiFind doctors who prescribe Niraparib rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Niraparib

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.